A Report of Eruptive Pruritic Papular Porokeratosis Treated with Abrocitinib.

JAK inhibitors abrocitinib eruptive pruritic papular porokeratosis itch porokeratosis pruritus

Journal

Clinical, cosmetic and investigational dermatology
ISSN: 1178-7015
Titre abrégé: Clin Cosmet Investig Dermatol
Pays: New Zealand
ID NLM: 101543449

Informations de publication

Date de publication:
2023
Historique:
received: 05 06 2023
accepted: 05 08 2023
medline: 21 8 2023
pubmed: 21 8 2023
entrez: 21 8 2023
Statut: epublish

Résumé

Eruptive pruritic papular porokeratosis (EPPP) is a subtype of porokeratosis (PK). EPPP is characterized by intense itching and challenging to treat in some cases. Herein, for the first time, a case of successful relief of EPPP treated with abrocitinib was reported. A 75-year-old male with a 60-year history of PK suddenly experienced severe itching in the past 6 months. The patient's use of antihistamines, prednisone, vitamin A derivatives, vitamin D derivatives, and

Identifiants

pubmed: 37601417
doi: 10.2147/CCID.S424310
pii: 424310
pmc: PMC10437098
doi:

Types de publication

Case Reports

Langues

eng

Pagination

2223-2227

Informations de copyright

© 2023 Xia and Jiang.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest in this work.

Références

Br J Dermatol. 2023 Jul 7;189(1):136-138
pubmed: 37093680
Int J Dermatol. 2023 Sep;62(9):e480-e483
pubmed: 37186302
J Dermatol. 1992 Feb;19(2):109-12
pubmed: 1377721
J Eur Acad Dermatol Venereol. 2023 Mar 27;:
pubmed: 36974430
Clin Cosmet Investig Dermatol. 2023 Jul 06;16:1741-1747
pubmed: 37435395
Dermatitis. 2023 Feb 27;:
pubmed: 36847309
Clin Exp Dermatol. 2023 Apr 27;48(5):532-533
pubmed: 36723952
Eur J Dermatol. 2021 Aug 26;:
pubmed: 34463291
Am J Clin Dermatol. 2021 Sep;22(5):693-707
pubmed: 34406619
J Clin Med. 2020 Nov 20;9(11):
pubmed: 33233866
Stem Cells. 2014 Jul;32(7):1878-89
pubmed: 24677703
JAMA Dermatol. 2019 Dec 1;155(12):1371-1379
pubmed: 31577341
Pharmaceutics. 2022 May 06;14(5):
pubmed: 35631587
J Dermatol. 2021 Aug;48(8):e382-e383
pubmed: 33960502

Auteurs

Jiali Xia (J)

Department of Dermatology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221002, People's Republic of China.

Guan Jiang (G)

Department of Dermatology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221002, People's Republic of China.

Classifications MeSH